Actemra Rival IL-6 Inhibitor Shown Effective in Trial
New IL-6 inhibitor brings ACR 50 to half of patients
Would you believe I just realized why the Biologics’ names end in “mab”? It is short for monoclonal antibody. Must be those blonde highlights.
A new monoclonal antibody referred to as ALD518 was tested on one hundred twenty-seven patients who took part in a Phase 2 clinical...Continue reading 7 Comments »
Read more